These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37273269)

  • 41. Dacarbazine-encapsulated solid lipid nanoparticles for skin cancer: physical characterization, stability,
    Bhattacharya S; Sharma S
    Front Oncol; 2023; 13():1102269. PubMed ID: 37152046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
    Hu L; Jia H; Luo Z; Liu C; Xing Q
    Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds.
    Subroto E; Andoyo R; Indiarto R
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride.
    Vaghasiya H; Kumar A; Sawant K
    Eur J Pharm Sci; 2013 May; 49(2):311-22. PubMed ID: 23557842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
    Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
    Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies.
    Gaur PK; Mishra S; Bajpai M; Mishra A
    Biomed Res Int; 2014; 2014():363404. PubMed ID: 24967360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment to the Antifungal Effects in vitro and the Ocular Pharmacokinetics of Solid-Lipid Nanoparticle in Rabbits.
    Liang Z; Zhang Z; Yang J; Lu P; Zhou T; Li J; Zhang J
    Int J Nanomedicine; 2021; 16():7847-7857. PubMed ID: 34876813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physicochemical and In Vitro Digestion Properties of Curcumin-Loaded Solid Lipid Nanoparticles with Different Solid Lipids and Emulsifiers.
    Yu Y; Chen D; Lee YY; Chen N; Wang Y; Qiu C
    Foods; 2023 May; 12(10):. PubMed ID: 37238863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies.
    Geszke-Moritz M; Moritz M
    Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():982-994. PubMed ID: 27524099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
    Kumar R; Singh A; Garg N; Siril PF
    Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
    You J; Wan F; de Cui F; Sun Y; Du YZ; Hu FQ
    Int J Pharm; 2007 Oct; 343(1-2):270-6. PubMed ID: 17706383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acyclovir-Loaded Solid Lipid Nanoparticles: Optimization, Characterization and Evaluation of Its Pharmacokinetic Profile.
    Hassan H; Bello RO; Adam SK; Alias E; Meor Mohd Affandi MMR; Shamsuddin AF; Basir R
    Nanomaterials (Basel); 2020 Sep; 10(9):. PubMed ID: 32916823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxiconazole nitrate solid lipid nanoparticles: formulation, in-vitro characterization and clinical assessment of an analogous loaded carbopol gel.
    Mahmoud RA; Hussein AK; Nasef GA; Mansour HF
    Drug Dev Ind Pharm; 2020 May; 46(5):706-716. PubMed ID: 32266837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells.
    Tran TH; Ramasamy T; Truong DH; Shin BS; Choi HG; Yong CS; Kim JO
    Pharm Res; 2014 Aug; 31(8):1978-88. PubMed ID: 24562809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery.
    Chen X; Peng LH; Shan YH; Li N; Wei W; Yu L; Li QM; Liang WQ; Gao JQ
    Int J Pharm; 2013 Apr; 447(1-2):171-81. PubMed ID: 23500766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
    Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
    Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.